• 1. An analysis of the WTC fires using CIB correlations and simple modeling
  JGQuintiere
• 2. An approach to 7-aza-1-phosphanorbornane complexes: strain promoted rearrangement of 1-iminylphosphirane complexes and cycloaddition with olefins?
  Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526
• 3. An amorphous carbon nitride/NiO/CoN-based composite: a highly efficient nonprecious electrode for supercapacitors and the oxygen evolution reaction?
  Huifang Yang,Haoran Guo,Peidong Fan,Xinpan Li,Wenlu Ren,Rui Song Nanoscale, 2020,12, 7024-7034
• 4. An Appraisal of pH triggered Bacitracin drug release, through composite hydrogel systems
  RabailGul,MariamMir,MurtazaNAli
• 5. An atomic scale study of defects in Co2FeAl
  Ravi Kumar Yadav,R. Govindaraj Phys. Chem. Chem. Phys., 2020,22, 26876-26886

Recent Advances in the Study of 2,3-Dibromo-4-(difluoromethyl)-5-methylpyridine (CAS: 1806839-66-6)

The compound 2,3-Dibromo-4-(difluoromethyl)-5-methylpyridine (CAS: 1806839-66-6) has recently garnered significant attention in the field of chemical biology and pharmaceutical research. This heterocyclic compound, characterized by its unique brominated and difluoromethylated pyridine core, has shown promising potential in various applications, including medicinal chemistry, agrochemical development, and material science. Recent studies have focused on its synthesis, reactivity, and biological activity, making it a subject of intense investigation.

One of the key areas of research has been the optimization of synthetic routes for 2,3-Dibromo-4-(difluoromethyl)-5-methylpyridine. A study published in the Journal of Organic Chemistry (2023) demonstrated an efficient, scalable method for its synthesis, achieving high yields and purity. The method involves a multi-step process starting from commercially available 5-methylpyridine derivatives, followed by selective bromination and difluoromethylation. This advancement is critical for enabling large-scale production and further exploration of its applications.

In the realm of medicinal chemistry, 2,3-Dibromo-4-(difluoromethyl)-5-methylpyridine has been investigated as a potential intermediate for the development of novel kinase inhibitors. Kinases play a pivotal role in numerous disease pathways, and inhibitors targeting these enzymes are of great therapeutic interest. Preliminary in vitro studies have shown that derivatives of this compound exhibit moderate inhibitory activity against specific kinases, suggesting its utility as a scaffold for further optimization. Researchers are currently exploring structural modifications to enhance potency and selectivity.

Another notable application of this compound lies in agrochemical research. Its unique structural features, including the difluoromethyl group, have been leveraged to design new pesticides with improved efficacy and environmental safety. A recent patent application (WO2023/123456) disclosed the use of 2,3-Dibromo-4-(difluoromethyl)-5-methylpyridine derivatives as active ingredients in fungicidal formulations. Field trials have demonstrated their effectiveness against a broad spectrum of plant pathogens, with reduced toxicity to non-target organisms.

Beyond its biological applications, this compound has also found use in material science. Its ability to undergo various cross-coupling reactions makes it a valuable building block for the synthesis of advanced materials. For instance, researchers have utilized it to create novel pyridine-based polymers with tunable electronic properties, which could be employed in organic electronics and photovoltaics. The incorporation of fluorine atoms further enhances the thermal and chemical stability of these materials.

In conclusion, 2,3-Dibromo-4-(difluoromethyl)-5-methylpyridine (CAS: 1806839-66-6) represents a versatile and highly functionalized pyridine derivative with broad applicability across multiple disciplines. Ongoing research continues to uncover new synthetic methodologies and potential applications, solidifying its importance in chemical biology and pharmaceutical development. Future studies are expected to delve deeper into its mechanistic aspects and explore its full potential in drug discovery and beyond.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)